25 February 2020 - Arizona Sen. Martha McSally is introducing a drug pricing bill this week that would allow Medicare to directly negotiate the prices of medicines “that are past their original patent expiration but still maintain a monopoly for that drug.”

McSally’s move is notable as Republicans have traditionally opposed allowing government intervention in drug price negotiations.

Only two House Republicans voted for House Democrats’ signature government drug price negotiation bill, H.R. 3 (116), which cleared the lower chamber late last year.

Read Politico article